(Q54313087)

27 May 2018

title

First clinical isolate of highly fluoroquinolone-resistant Escherichia coli in Scandanavia. (English)

1 reference

27 May 2018

1 reference

M Jonsson

1

1 reference

27 May 2018

M Walder

series ordinal

2

1 reference

27 May 2018

A Forsgren

series ordinal

3

1 reference

27 May 2018

publication date

1 November 1990

1 reference

27 May 2018

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

27 May 2018

volume

9

1 reference

27 May 2018

issue

11

1 reference

27 May 2018

page(s)

851-853

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01967392

exact match

0 references

cites work

The new quinolones and their combinations with other agents for therapy of severe infections

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

Norfloxacin resistance in a clinical isolate of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967392

Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance

21 January 2018

1 reference

12 December 2020

A Critical Evaluation of Nalidixic Acid in Urinary-Tract Infections

1 reference

12 December 2020

Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.

1 reference

12 December 2020

[Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin]

1 reference

12 December 2020

Norfloxacin for the treatment of uncomplicated urinary tract infections

1 reference

12 December 2020

Gain of antibiotic sensitivity accompanying emergence of clinical ciprofloxacin resistance.

1 reference

12 December 2020

In-vitro selection of bacteria resistant to the 4-quinolone agents.

1 reference

12 December 2020

Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter

1 reference

12 December 2020

Norfloxacin vs. pivmecillinam in the treatment of uncomplicated lower urinary tract infections in hospitalized elderly patients.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01967392

1 reference

27 May 2018

1 reference

27 May 2018